Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Djulbegovic

Showing results (61-70 of 315) with videos related to

Pageof 32
Sort By:
Lancet (London, England)|December 13, 2006
Screening mammography at 40-49 years: regret or no regret?Benjamin Djulbegovic, Gary H Lyman
Blood Advances|September 20, 2023
Hematology referral madness syndromeBenjamin Djulbegovic, Charles S Greenberg
JAMA|October 1, 2014
Evidence-based practice is not synonymous with delivery of uniform health careBenjamin Djulbegovic, Gordon H Guyatt
Lancet (London, England)|February 21, 2017
Progress in evidence-based medicine: a quarter century onBenjamin Djulbegovic, Gordon H Guyatt
Cancer Treatment Reviews|October 18, 2005
The challenge of systematic reviews of diagnostic and staging studies in cancerGary H Lyman, Benjamin Djulbegovic
The Lancet. Haematology|May 3, 2016
Thrombotic thrombocytopenic purpura: gaining knowledgeCharles L Bennett, Benjamin Djulbegovic
Lancet (London, England)|November 23, 2017
On evidence-based medicine - Authors' replyBenjamin Djulbegovic, Gordon H Guyatt
Blood Advances|January 20, 2026
How to Determine the Optimal Duration of Anticoagulation for VTE: An Evidence-Based Decision-Analytical ApproachBenjamin Djulbegovic, Charles S Greenberg
European Journal of Clinical Investigation|September 26, 2018
Precision medicine for individual patients should use population group averages and larger, not smaller, groupsBenjamin Djulbegovic, John P A Ioannidis
Accountability in Research|March 3, 2004
The importance of preservation of the ethical principle of equipoise in the design of clinical trials: relative impact of the methodological quality domains on the treatment effect in randomized controlled trialsBenjamin Djulbegovic, Alan Cantor, Mike Clarke
Pageof 32

Showing results (61-70 of 315) with videos related to

Sort By:
Pageof 32
Lancet (London, England)|December 13, 2006
Screening mammography at 40-49 years: regret or no regret?Benjamin Djulbegovic, Gary H Lyman
Blood Advances|September 20, 2023
Hematology referral madness syndromeBenjamin Djulbegovic, Charles S Greenberg
JAMA|October 1, 2014
Evidence-based practice is not synonymous with delivery of uniform health careBenjamin Djulbegovic, Gordon H Guyatt
Lancet (London, England)|February 21, 2017
Progress in evidence-based medicine: a quarter century onBenjamin Djulbegovic, Gordon H Guyatt
Cancer Treatment Reviews|October 18, 2005
The challenge of systematic reviews of diagnostic and staging studies in cancerGary H Lyman, Benjamin Djulbegovic
The Lancet. Haematology|May 3, 2016
Thrombotic thrombocytopenic purpura: gaining knowledgeCharles L Bennett, Benjamin Djulbegovic
Lancet (London, England)|November 23, 2017
On evidence-based medicine - Authors' replyBenjamin Djulbegovic, Gordon H Guyatt
Blood Advances|January 20, 2026
How to Determine the Optimal Duration of Anticoagulation for VTE: An Evidence-Based Decision-Analytical ApproachBenjamin Djulbegovic, Charles S Greenberg
European Journal of Clinical Investigation|September 26, 2018
Precision medicine for individual patients should use population group averages and larger, not smaller, groupsBenjamin Djulbegovic, John P A Ioannidis
Accountability in Research|March 3, 2004
The importance of preservation of the ethical principle of equipoise in the design of clinical trials: relative impact of the methodological quality domains on the treatment effect in randomized controlled trialsBenjamin Djulbegovic, Alan Cantor, Mike Clarke
Pageof 32